Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ADC Therapeutics SA (ADCT)

NYSE - NYSE Delayed Price. Currency in USD
3.5900-0.0800 (-2.18%)
At close: 01:00PM EST
3.5600 -0.03 (-0.84%)
After hours: 02:35PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/25/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
284.96M374.25M610.64M1.13B1.55B2.08B
Enterprise Value
20.76M100.79M282.33M763.55M1.12B1.81B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.803.947.5933.2491.70542.91
Price/Book (mrq)
2.723.243.766.798.288.54
Enterprise Value/Revenue
0.131.3216.3316.4265.86137.77
Enterprise Value/EBITDA
-0.14-2.56-5.05-95.21-24.31-27.25

Trading Information

Stock Price History

Beta (5Y Monthly) 1.18
52-Week Change 3-83.51%
S&P500 52-Week Change 3-13.51%
52 Week High 323.2830
52 Week Low 33.5700
50-Day Moving Average 34.5394
200-Day Moving Average 38.6965

Share Statistics

Avg Vol (3 month) 3345.41k
Avg Vol (10 day) 3792.52k
Shares Outstanding 577.65M
Implied Shares Outstanding 6N/A
Float 838.64M
% Held by Insiders 152.28%
% Held by Institutions 151.52%
Shares Short (Nov 14, 2022) 46.23M
Short Ratio (Nov 14, 2022) 412.04
Short % of Float (Nov 14, 2022) 418.45%
Short % of Shares Outstanding (Nov 14, 2022) 48.03%
Shares Short (prior month Oct 13, 2022) 46.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin -105.67%
Operating Margin (ttm)-111.81%

Management Effectiveness

Return on Assets (ttm)-18.77%
Return on Equity (ttm)-113.68%

Income Statement

Revenue (ttm)157.12M
Revenue Per Share (ttm)2.03
Quarterly Revenue Growth (yoy)480.50%
Gross Profit (ttm)-125.48M
EBITDA -174.49M
Net Income Avi to Common (ttm)-166.02M
Diluted EPS (ttm)-2.5420
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)380.86M
Total Cash Per Share (mrq)4.86
Total Debt (mrq)337.8M
Total Debt/Equity (mrq)322.38
Current Ratio (mrq)5.00
Book Value Per Share (mrq)1.34

Cash Flow Statement

Operating Cash Flow (ttm)-146.33M
Levered Free Cash Flow (ttm)-83.25M
Advertisement
Advertisement